Nationally Recognized Health Services Researcher and Entrepreneur Dr. Dena Bravata Joins Vivante Health’s Clinical Advisory Board
11 avr. 2024 08h00 HE
|
Vivante Health
Dr. Dena Bravata Joins Vivante Health’s Clinical Advisory Board
Inflammatory Bowel Disease Expert and Harvard Medical School Faculty Dr. Hamed Khalili Joins Vivante Health’s Clinical Advisory Board
26 févr. 2024 11h00 HE
|
Vivante Health
Inflammatory Bowel Disease Expert and Harvard Medical School Faculty Dr. Hamed Khalili Joins Vivante Health’s Clinical Advisory Board
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
08 févr. 2024 08h05 HE
|
Palisade Bio, Inc.
Bruce Sands, MD, MS., Dr. Burrill B. Crohn Professor of Medicine, Icahn School of Medicine at Mount Sinai and System Chief, Division of Gastroenterology, Mount Sinai Health SystemFlorian Rieder, MD,...
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board
05 déc. 2023 04h00 HE
|
AKAMPION
- Two renowned oncology experts to support the development of Thermosome's clinical candidate THE001 Munich, Germany – December 05, 2023 – Thermosome, a drug development company specializing...
Retia Medical Announces Bernd Saugel has Joined the Clinical Advisory Board
01 juin 2021 09h00 HE
|
Retia Medical, LLC
VALHALLA, N.Y., June 01, 2021 (GLOBE NEWSWIRE) -- Retia Medical, an innovator in hemodynamic monitoring that helps clinicians guide care to prevent complications from high-risk surgeries such as...
Medical Leaders Join BioSig Clinical Advisory Board
28 nov. 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
VBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards
26 sept. 2018 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...